A model-informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy.

IF 3.1 3区 医学 Q2 PHARMACOLOGY & PHARMACY CPT: Pharmacometrics & Systems Pharmacology Pub Date : 2024-10-03 DOI:10.1002/psp4.13246
Jongjin Kim, Juan Francisco Morales, Sanghoon Kang, Marian Klose, Rebecca J Willcocks, Michael J Daniels, Ramona Belfiore-Oshan, Glenn A Walter, William D Rooney, Krista Vandenborne, Sarah Kim
{"title":"A model-informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy.","authors":"Jongjin Kim, Juan Francisco Morales, Sanghoon Kang, Marian Klose, Rebecca J Willcocks, Michael J Daniels, Ramona Belfiore-Oshan, Glenn A Walter, William D Rooney, Krista Vandenborne, Sarah Kim","doi":"10.1002/psp4.13246","DOIUrl":null,"url":null,"abstract":"<p><p>Quantitative model-based clinical trial simulation tools play a critical role in informing study designs through simulation before actual execution. These tools help drug developers explore various trial scenarios in silico to select a clinical trial design to detect therapeutic effects more efficiently, therefore reducing time, expense, and participants' burden. To increase the usability of the tools, user-friendly and interactive platforms should be developed to navigate various simulation scenarios. However, developing such tools challenges researchers, requiring expertise in modeling and interface development. This tutorial aims to address this gap by guiding developers in creating tailored R Shiny apps, using an example of a model-based clinical trial simulation tool that we developed for Duchenne muscular dystrophy (DMD). In this tutorial, the structural framework, essential controllers, and visualization techniques for analysis are described, along with key code examples such as criteria selection and power calculation. A virtual population was created using a machine learning algorithm to enlarge the available sample size to simulate clinical trial scenarios in the presented tool. In addition, external validation of the simulated outputs was conducted using a placebo arm of a recently published DMD trial. This tutorial will be particularly useful for developing clinical trial simulation tools based on DMD progression models for other end points and biomarkers. The presented strategies can also be applied to other diseases.</p>","PeriodicalId":10774,"journal":{"name":"CPT: Pharmacometrics & Systems Pharmacology","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CPT: Pharmacometrics & Systems Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/psp4.13246","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Quantitative model-based clinical trial simulation tools play a critical role in informing study designs through simulation before actual execution. These tools help drug developers explore various trial scenarios in silico to select a clinical trial design to detect therapeutic effects more efficiently, therefore reducing time, expense, and participants' burden. To increase the usability of the tools, user-friendly and interactive platforms should be developed to navigate various simulation scenarios. However, developing such tools challenges researchers, requiring expertise in modeling and interface development. This tutorial aims to address this gap by guiding developers in creating tailored R Shiny apps, using an example of a model-based clinical trial simulation tool that we developed for Duchenne muscular dystrophy (DMD). In this tutorial, the structural framework, essential controllers, and visualization techniques for analysis are described, along with key code examples such as criteria selection and power calculation. A virtual population was created using a machine learning algorithm to enlarge the available sample size to simulate clinical trial scenarios in the presented tool. In addition, external validation of the simulated outputs was conducted using a placebo arm of a recently published DMD trial. This tutorial will be particularly useful for developing clinical trial simulation tools based on DMD progression models for other end points and biomarkers. The presented strategies can also be applied to other diseases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
具有图形用户界面的杜氏肌肉萎缩症模型临床试验模拟工具。
基于定量模型的临床试验模拟工具在实际执行前通过模拟为研究设计提供信息方面发挥着至关重要的作用。这些工具可以帮助药物开发人员在硅学中探索各种试验方案,从而选择临床试验设计,更有效地检测治疗效果,从而减少时间、费用和参与者的负担。为提高工具的可用性,应开发用户友好的交互式平台,以浏览各种模拟场景。然而,开发此类工具对研究人员提出了挑战,需要建模和界面开发方面的专业知识。本教程以我们为杜氏肌营养不良症(DMD)开发的基于模型的临床试验模拟工具为例,旨在指导开发人员创建量身定制的 R Shiny 应用程序,从而弥补这一不足。本教程介绍了结构框架、基本控制器和可视化分析技术,以及标准选择和功率计算等关键代码示例。使用机器学习算法创建了一个虚拟人群,以扩大可用样本量,从而在介绍的工具中模拟临床试验场景。此外,还使用最近发表的一项 DMD 试验的安慰剂臂对模拟输出进行了外部验证。本教程对于开发基于 DMD 进展模型、适用于其他终点和生物标记物的临床试验模拟工具特别有用。所介绍的策略也可应用于其他疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.00
自引率
11.40%
发文量
146
审稿时长
8 weeks
期刊最新文献
A model-informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy. Physiology-based pharmacokinetic model with relative transcriptomics to evaluate tissue distribution and receptor occupancy of anifrolumab. Interim analysis, a tool to enhance efficiency of pharmacokinetic studies: Pharmacokinetics of rifampicin in lactating mother-infant pairs. PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first-pass metabolism? Immunostimulatory/Immunodynamic model of mRNA-1273 to guide pediatric vaccine dose selection.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1